Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
The Center for Cancer Therapeutic Innovation (CCTI) conducts phase I clinical trials for many types of solid tumor cancers. Patients and referring physicians are welcome to contact us for more information about current phase I clinical trials for cancer.
If you are a patient interested in finding out more about phase I trials, please contact us using this secure online form, by calling 617-632-3332, via email at email@example.com, or by fax at 617-632-2630.
If you are a physician interested in referring a patient to a phase I trial, please contact us using this secure online form, by calling 617-632-3332, via email at firstname.lastname@example.org, or by fax at 617-632-2630.
CCTI New Patient Coordinator: email@example.com
CCTI nursing contact: firstname.lastname@example.org
Center for Cancer Therapeutic Innovation
Dana-Farber Cancer Institute
450 Brookline Avenue, Yawkey 6
Boston, MA 02215
New Patient Appointments
Clinical Trials Questions?